Adimmune signs an MOU with an eye on IndonesiaBy Kao Shih-ching / Staff reporterAdimmune Corp (國光生技) on Thursday signed a memorandum of understanding (MOU) with Indonesia-based industrial-estate developer PT Berkah Kawasan Manyar Sejahtera (BKMS) as it eyes a new factory in Indonesia. BKMS, a subsidiary of AKR Corporindo Tbk PT, helps foreign companies invest in Java Integrated Industrial Ports and Estate, which has been designated a special economic zone, Adimmune said. “The zone is a strong candidate for overseas expansion, due to its infrastructure and advantageous policies, in addition to the large consumer base in Indonesia,” Pan said. It would focus on contract development and manufacturing to help clients develop their own vaccines, Pan said. Adimmune has conducted phase 1 trials in Taiwan and is considering phase 2 human trials in Indonesia, Pan said, adding that talks are ongoing with Indonesian regulators.

Source: Taipei Times July 09, 2021 15:56 UTC